She leads the Lung Immunology Group, with two areas of research: first, basic studies on how immune responses are controlled in the lungs to prevent lung injury and fibrosis; second, translation of this work to understand disease mechanisms, to improve patient stratification, and to discover targets for new therapies for sarcoidosis and idiopathic pulmonary fibrosis (IPF).